These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 31348886)

  • 41. Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes.
    Ringe RP; Pugach P; Cottrell CA; LaBranche CC; Seabright GE; Ketas TJ; Ozorowski G; Kumar S; Schorcht A; van Gils MJ; Crispin M; Montefiori DC; Wilson IA; Ward AB; Sanders RW; Klasse PJ; Moore JP
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487280
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies.
    Mabvakure BM; Scheepers C; Garrett N; Abdool Karim S; Williamson C; Morris L; Moore PL
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Putative rhesus macaque germline predecessors of human broadly HIV-neutralizing antibodies: differences from the human counterparts and implications for HIV-1 vaccine development.
    Yuan T; Li J; Zhang Y; Wang Y; Streaker E; Dimitrov DS; Zhang MY
    Vaccine; 2011 Sep; 29(40):6903-10. PubMed ID: 21807049
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations.
    Andersson AC; Ragonnaud E; Seaton KE; Sawant S; Folgori A; Colloca S; Labranche C; Montefiori DC; Tomaras GD; Holst PJ
    Vaccine; 2016 Oct; 34(44):5344-5351. PubMed ID: 27633665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extensive dissemination and intraclonal maturation of HIV Env vaccine-induced B cell responses.
    Phad GE; Pushparaj P; Tran K; Dubrovskaya V; Àdori M; Martinez-Murillo P; Vázquez Bernat N; Singh S; Dionne G; O'Dell S; Bhullar K; Narang S; Sorini C; Villablanca EJ; Sundling C; Murrell B; Mascola JR; Shapiro L; Pancera M; Martin M; Corcoran M; Wyatt RT; Karlsson Hedestam GB
    J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31704807
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations.
    Williams WB; Zhang J; Jiang C; Nicely NI; Fera D; Luo K; Moody MA; Liao HX; Alam SM; Kepler TB; Ramesh A; Wiehe K; Holland JA; Bradley T; Vandergrift N; Saunders KO; Parks R; Foulger A; Xia SM; Bonsignori M; Montefiori DC; Louder M; Eaton A; Santra S; Scearce R; Sutherland L; Newman A; Bouton-Verville H; Bowman C; Bomze H; Gao F; Marshall DJ; Whitesides JF; Nie X; Kelsoe G; Reed SG; Fox CB; Clary K; Koutsoukos M; Franco D; Mascola JR; Harrison SC; Haynes BF; Verkoczy L
    Nat Commun; 2017 Nov; 8(1):1732. PubMed ID: 29170366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies.
    LaBranche CC; Henderson R; Hsu A; Behrens S; Chen X; Zhou T; Wiehe K; Saunders KO; Alam SM; Bonsignori M; Borgnia MJ; Sattentau QJ; Eaton A; Greene K; Gao H; Liao HX; Williams WB; Peacock J; Tang H; Perez LG; Edwards RJ; Kepler TB; Korber BT; Kwong PD; Mascola JR; Acharya P; Haynes BF; Montefiori DC
    PLoS Pathog; 2019 Sep; 15(9):e1008026. PubMed ID: 31527908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Requirements for the Induction of Broadly Neutralizing Antibodies against HIV-1 by Vaccination].
    Vzorov AN; Uryvaev LV
    Mol Biol (Mosk); 2017; 51(6):945-957. PubMed ID: 29271959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.
    Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X
    J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.
    García-Arriaza J; Perdiguero B; Heeney JL; Seaman MS; Montefiori DC; Yates NL; Tomaras GD; Ferrari G; Foulds KE; Roederer M; Self SG; Borate B; Gottardo R; Phogat S; Tartaglia J; Barnett SW; Burke B; Cristillo AD; Weiss DE; Lee C; Kibler KV; Jacobs BL; Wagner R; Ding S; Pantaleo G; Esteban M
    J Virol; 2017 May; 91(9):. PubMed ID: 28179536
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch.
    MacLeod DT; Choi NM; Briney B; Garces F; Ver LS; Landais E; Murrell B; Wrin T; Kilembe W; Liang CH; Ramos A; Bian CB; Wickramasinghe L; Kong L; Eren K; Wu CY; Wong CH; ; Kosakovsky Pond SL; Wilson IA; Burton DR; Poignard P
    Immunity; 2016 May; 44(5):1215-26. PubMed ID: 27192579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural Survey of Broadly Neutralizing Antibodies Targeting the HIV-1 Env Trimer Delineates Epitope Categories and Characteristics of Recognition.
    Chuang GY; Zhou J; Acharya P; Rawi R; Shen CH; Sheng Z; Zhang B; Zhou T; Bailer RT; Dandey VP; Doria-Rose NA; Louder MK; McKee K; Mascola JR; Shapiro L; Kwong PD
    Structure; 2019 Jan; 27(1):196-206.e6. PubMed ID: 30471922
    [TBL] [Abstract][Full Text] [Related]  

  • 53. VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing Lineage.
    Shen CH; DeKosky BJ; Guo Y; Xu K; Gu Y; Kilam D; Ko SH; Kong R; Liu K; Louder MK; Ou L; Zhang B; Chao CW; Corcoran MM; Feng E; Huang J; Normandin E; O'Dell S; Ransier A; Rawi R; Sastry M; Schmidt SD; Wang S; Wang Y; Chuang GY; Doria-Rose NA; Lin B; Zhou T; Boritz EA; Connors M; Douek DC; Karlsson Hedestam GB; Sheng Z; Shapiro L; Mascola JR; Kwong PD
    Cell Host Microbe; 2020 Apr; 27(4):531-543.e6. PubMed ID: 32130953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Neutralizing Antibody Response to the HIV-1 Env Protein.
    Moore PL
    Curr HIV Res; 2018; 16(1):21-28. PubMed ID: 29173180
    [TBL] [Abstract][Full Text] [Related]  

  • 55. B cell clonal lineage alterations upon recombinant HIV-1 envelope immunization of rhesus macaques.
    Yacoob C; Lange MD; Cohen K; Lathia K; Feng J; Glenn J; Carbonetti S; Oliver B; Vigdorovich V; Sather DN; Stamatatos L
    PLoS Pathog; 2018 Jun; 14(6):e1007120. PubMed ID: 29933399
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques.
    Xu L; Pegu A; Rao E; Doria-Rose N; Beninga J; McKee K; Lord DM; Wei RR; Deng G; Louder M; Schmidt SD; Mankoff Z; Wu L; Asokan M; Beil C; Lange C; Leuschner WD; Kruip J; Sendak R; Kwon YD; Zhou T; Chen X; Bailer RT; Wang K; Choe M; Tartaglia LJ; Barouch DH; O'Dell S; Todd JP; Burton DR; Roederer M; Connors M; Koup RA; Kwong PD; Yang ZY; Mascola JR; Nabel GJ
    Science; 2017 Oct; 358(6359):85-90. PubMed ID: 28931639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation.
    Zhou T; Doria-Rose NA; Cheng C; Stewart-Jones GBE; Chuang GY; Chambers M; Druz A; Geng H; McKee K; Kwon YD; O'Dell S; Sastry M; Schmidt SD; Xu K; Chen L; Chen RE; Louder MK; Pancera M; Wanninger TG; Zhang B; Zheng A; Farney SK; Foulds KE; Georgiev IS; Joyce MG; Lemmin T; Narpala S; Rawi R; Soto C; Todd JP; Shen CH; Tsybovsky Y; Yang Y; Zhao P; Haynes BF; Stamatatos L; Tiemeyer M; Wells L; Scorpio DG; Shapiro L; McDermott AB; Mascola JR; Kwong PD
    Cell Rep; 2017 Apr; 19(4):719-732. PubMed ID: 28445724
    [TBL] [Abstract][Full Text] [Related]  

  • 58. BLyS-mediated modulation of naive B cell subsets impacts HIV Env-induced antibody responses.
    Dosenovic P; Soldemo M; Scholz JL; O'Dell S; Grasset EK; Pelletier N; Karlsson MC; Mascola JR; Wyatt RT; Cancro MP; Karlsson Hedestam GB
    J Immunol; 2012 Jun; 188(12):6018-26. PubMed ID: 22561155
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fusion peptide priming reduces immune responses to HIV-1 envelope trimer base.
    Corrigan AR; Duan H; Cheng C; Gonelli CA; Ou L; Xu K; DeMouth ME; Geng H; Narpala S; O'Connell S; Zhang B; Zhou T; Basappa M; Boyington JC; Chen SJ; O'Dell S; Pegu A; Stephens T; Tsybovsky Y; van Schooten J; Todd JP; Wang S; ; Doria-Rose NA; Foulds KE; Koup RA; McDermott AB; van Gils MJ; Kwong PD; Mascola JR
    Cell Rep; 2021 Apr; 35(1):108937. PubMed ID: 33826898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure.
    Kwong PD; Mascola JR
    Immunity; 2018 May; 48(5):855-871. PubMed ID: 29768174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.